首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 再生醫學 > 臍帶血幹細胞：全球市場概要
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

臍帶血幹細胞：全球市場概要

Cord Blood Stem Cells - A Global Market Overview

出版商 Industry Experts
出版日期 2011年10月 商品編碼 218329
內容資訊 英文 282 Pages
價格
US $ 4050 PDF by E-mail (Single user license)
US $ 5850 PDF by E-mail (Global site license)


臍帶血幹細胞：全球市場概要 是由出版商Industry Experts在2011年10月所出版的。 這份英文市場調查報告書包含282 Pages 價格從美金4050起跳。

簡介

受科學技術發展帶動，用於再生醫學臍帶血之保存數也有所增加。保存小孩的臍帶血，其幹細胞未來將可能用於治療上。幼兒的臍帶血提供了心臟不全等未來無法治療之突發疾病，是未來最理想之治療方式。而透過最新的再生醫學，使用自己本身之臍帶血，將可獲得最好之效果。

本報告為，以北美、歐洲、亞太地區等地區別，分析全球臍帶血幹細胞市場，並匯整市場參與主要企業簡介等，以下列摘要形式闡述。

第1章 全球市場展望

  • 簡介
  • 產品區隔
    • 球臍帶血幹細胞之主要技術
    • 球臍帶血幹細胞之治療領域
  • 應用分析
  • 臍帶血銀行
    • 臍帶血銀行途徑
    • 爭論及挑戰
    • 各國臍帶血銀行之機會及簡介
  • 市場趨勢
  • 主要趨勢
  • 主要商業趨勢
  • 主要產品趨勢
  • 全球市場概要
    • 臍帶血技術別之市場概要
    • 臍帶血治療領域別之市場概要
    • 地區別臍帶血技術之市場概要
    • 地區別臍帶血治療之市場概要

第2章 地區別市場展望

  • 地區別市場概要
    • 北美
      • 地區別幹細胞技術別
      • 幹細胞治療領域別
      • 北美幹細胞技術市場概要
        • 幹細胞移植
        • 臍帶血銀行
        • 輸血
        • 異種移植
      • 主要企業
    • 歐洲
      • 地區別幹細胞技術別
      • 幹細胞治療領域別
      • 幹細胞技術市場概要
        • 幹細胞移植
        • 臍帶血銀行
        • 輸血
        • 異種移植
      • 主要企業
    • 亞太地區各國
      • 地區別幹細胞技術別
      • 幹細胞治療領域別
      • 幹細胞技術市場概要
      • 主要企業
    • 其他各國
      • 地區別幹細胞技術別
      • 幹細胞治療領域別
      • 幹細胞技術市場概要
        • 幹細胞移植
        • 臍帶血銀行
        • 輸血
        • 異種移植
      • 主要企業

第3章 產業指南\

  • 國營臍帶血銀行
  • 私人臍帶血銀行
    • 北美
    • 歐洲
    • 亞太地區各國
    • 其他各國

第4章 附錄

圖表

目錄

Abstract

Description

Advancements in science and technology have enabled in increasing the number of preserved cord blood units being used in regenerative medicine applications. Expectant parents can decide to store their baby' s cord blood in a family bank and the stem cells are immediately available for use in medical treatments, such as future therapies requiring repair or replacement of damaged heart tissues. An infant' s cord blood offers the most ideal option for congenital heart defect or for future unforeseen and sudden occurrences, such as a serious heart attack. Latest scientific evidence offered by regenerative medicine has proved that using one' s own stem cells is likely to deliver the most favorable outcomes.

Cord blood stem cell technologies analyzed in this study include Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant. The report is also analyses the global market for stem cell therapeutic areas comprising Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other. The report analyses the global market in terms of USD Million.

The report reviews, analyses and projects the cord blood stem cells market for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 21 independent countries across Europe - The United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe; North America - the United States, Canada and Mexico; Asia-Pacific - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific; Rest of World - Brazil, Columbia, Argentina and Israel.

This 282 page global market report includes 129 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market value by geographic regions, cord blood stem cell technologies and therapeutic areas.

The report covers the brief business profiles of 58 key global players and 86 major players across North America - 42; Europe - 13; Asia-Pacific - 24; and Rest of World - 7. The report also provides the listing of the companies engaged in collection, processing and banking of cord blood stem cells. This list also includes the companies engaged in the treatment of deadly diseases using CB stem cells. The global list covers the addresses, contact numbers and the website addresses of 295 private and 87 public cord blood banks.

Table of Contents

1. GLOBAL MARKET PERSPECTIVE

  • 1.1 INTRODUCTION
  • 1.2 PRODUCT SEGMENTATION
    • 1.2.1 Key Technologies of Cord Blood Stem Cells
      • 1.2.1.1 Stem Cell Transplant
      • 1.2.1.1.1 Pros and Cons of Cord Blood Treatment
      • 1.2.1.2 Cord Blood Banking
      • 1.2.1.3 Blood Transfusion
      • 1.2.1.4 Cell Based Genetics
      • 1.2.1.5 Xenotransplant
    • 1.2.2 Treatment Procedures of Cord Blood
      • 1.2.2.1 Allogeneic Procedures
      • 1.2.2.2 Autologous Procedures
    • 1.2.3 Therapeutic Areas of Cord Blood Stem Cells
      • 1.2.3.1 Neurology
      • 1.2.3.2 Oncology
      • 1.2.3.3 Cardiology
        • 1.2.3.3.1 Cardiovascular Disease and Cord Blood Stem Cells
        • 1.2.3.3.1.1 Repairing Blood Vessels and Enhancing Ventricular Function
        • 1.2.3.3.1.2 In Vitro Studies in Cardiomyocytes and Cord Blood Demonstrate Promise
        • 1.2.3.3.1.3 Congenital Heart Defects and Cord Blood
        • 1.2.3.3.1.4 Advances in Peripheral Vascular Disease
      • 1.2.3.4 Cartilage
      • 1.2.3.5 Blood Disorders
      • 1.2.3.6 Diabetes
        • 1.2.3.6.1 Diabetes and Cord Blood Stem Cells
          • 1.2.3.6.1.1 Diabetic Wound Healing and Cord Blood
          • 1.2.3.6.1.2 Recent Scientific Studies
      • 1.2.3.7 Dermatology
        • 1.2.3.7.1 A Recent Cord Blood Case Study
  • 1.3 APPLICATION ANALYSIS
    • 1.3.1 The Collection of Cord Blood Units - Global
    • 1.3.2 The Collection of Cord Blood Units - Select Countries
    • 1.3.3 Cord Blood Transplants - Recent Case Studies
      • 1.3.3.1 CASET STUDY I - AUTOLOGOUS UMBILICAL CORD BLOOD TRANSFUSION IN YOUNGER CHILDREN HAVING TYPE 1 DIABETES
      • 1.3.3.2 CASE STUDY II - WHAT CORD BLOOD TRANSFUSIONS HAVE ON OFFER
      • 1.3.3.3 CASE STUDY III - BLOOD TRANSFUSIONS: TO CHOOSE OR NOT TO CHOOSE
      • 1.3.3.4 CASE STUDY IV - CORD BLOOD: POSITIVES AND NEGATIVES
      • 1.3.3.5 CASE STUDY V - UMBILICAL CORD BLOOD STEM CELL TRANSPLANT BENEFITS CEREBRAL PALSY
      • 1.3.3.6 CASE STUDY VI - SALVAGING LIFE OF A YOUNG GIRL USING HER BABY BROTHER' S CORD BLOOD
  • 1.4 CORD BLOOD BANKING - SNAPSHOTS
    • 1.4.1 The Process of Cord Blood Banking
      • 1.4.1.1 Types of Cord Blood Banking
        • 1.4.1.1.1 Public Cord Blood Banks
        • 1.4.1.1.2 Private Cord Blood Banks
    • 1.4.2 Controversies and Challenges
    • 1.4.3 Opportunities and Guidelines for Cord Blood Banking in Select Countries
      • 1.4.3.1 Australia
      • 1.4.3.2 Brazil
      • 1.4.3.3 Canada
      • 1.4.3.4 China
      • 1.4.3.5 Colombia
      • 1.4.3.6 European Union
        • 1.4.3.6.1 France
        • 1.4.3.6.2 Germany
        • 1.4.3.6.3 Greece
        • 1.4.3.6.4 Italy
        • 1.4.3.6.5 The Netherlands
        • 1.4.3.6.6 Poland
        • 1.4.3.6.7 Spain
        • 1.4.3.6.8 The United Kingdom
      • 1.4.3.7 India
      • 1.4.3.8 Japan
      • 1.4.3.9 Malaysia
      • 1.4.3.10 Singapore
      • 1.4.3.11 South Korea
      • 1.4.3.12 Taiwan
      • 1.4.3.13 The United States
  • 1.5 MARKET TRENDS
    • 1.5.1 Collection of Stem Cells After Birth Using a New Method
    • 1.5.2 European Hematology Association (EHA) 2011 Congress Validates Cord Blood Stem Cell Transplantation Benefits
    • 1.5.3 Cord Blood Banking: Gaining Wider Acceptance
      • 1.5.3.1 Private Vs. Public Cord Blood Banks
      • 1.5.3.2 Rationale Behind Cord Blood Banking
      • 1.5.3.3 Cord Blood in Comparison to Bone Marrow
      • 1.5.3.4 Cord Blood Successes
      • 1.5.3.5 A List of Diseases Currently Treated Using Cord Blood
        • 1.5.3.5.1 Cerebral Palsy
        • 1.5.3.5.2 Leukemias
        • 1.5.3.5.3 Myelodysplastic Syndromes (Also called Pre-Leukemia)
        • 1.5.3.5.4 Lymphomas
        • 1.5.3.5.5 Inherited Red Cell (Erythrocyte) Abnormalities
        • 1.5.3.5.6 Other Disorders of Blood Cell Proliferation
        • 1.5.3.5.7 Bone Marrow and Other Cancers
      • 1.5.3.6 Benefits of Cord Blood Storage
    • 1.5.4 Tissue Reconstruction with Fat Stem Cells: A Fine Line Between Clinical and Cosmetic Needs
    • 1.5.5 Using Human Umbilical Cord Blood for Wound Healing, Burns, and Brain Injury in Combat Zones
      • 1.5.5.1 HUCB Transfusion and its Importance
      • 1.5.5.2 HUCB, Wounds, and Bone Nonunion
      • 1.5.5.3 HUCB and Burns
      • 1.5.5.4 Wars and Traumatic Brain Injury (TBI)
      • 1.5.5.5 Future Course
      • 1.5.5.6 Availability, Safety, and Dosage of HUCB
      • 1.5.5.7 In Conclusion
    • 1.5.6 Cord Blood Stem Cells to the Rescue of a Girl Afflicted with Brain Cancer in Spain
    • 1.5.7 Stem Cells for Breast Reconstructive Surgery
    • 1.5.8 Cord Blood Stem Cells Studied for Pediatric Traumatic Brain Injury by University of Texas (UT) Health
    • 1.5.9 Cord Blood Transplant from Cryobanks Offers a New Lease of Life for a 7 Year Old Girl
    • 1.5.10 Stem Cells Therapy: Latest Trends
    • 1.5.11 Umbilical Cord Blood Collection and storage for Hematopoietic Cell Transplantation
    • 1.5.12 Human Umbilical Cord Blood Cells Rejuvenates Neural Stem Cells
    • 1.5.13 Umbilical Cord Blood Aids in Building New Heart-Valves
    • 1.5.14 Cord Blood Stem Cells - A Non-Controversial Option
    • 1.5.15 Cord Blood Banking: Envisioned for the Protection from Deadly Diseases
    • 1.5.16 CBR Backs Family Cord Blood Banking Act
    • 1.5.17 Cord Blood Transplants - A New Phenomenon in Treatment for Life Threatening Diseases
    • 1.5.18 Cord Blood Stem Cells Produces Insulin for Diabetes Treatment
  • 1.6 KEY GLOBAL PLAYERS
  • 1.7 KEY BUSINESS TRENDS
    • Cord Blood America in an Agreement with Regence
    • Cord Blood America Takes Over Assets of NeoCells
    • BioLife Solutions Leads in Supply of Cryopreservation Media for Stem Cells
    • Cord Blood America, Horizon Healthcare Services in an Agreement
    • CordLife Offers India' s First Successful Mixed Stem Cell (Cord Blood and Bone Marrow) Transplant
    • StemCyte, Sharp HealthCare in Cord Blood Collection Partnership
    • Cryo-Save, Lazaron Biotechnologies in a Joint Venture
    • Dual Cord Blood Processing Capabilities from StemCyte
    • Cord Blood America' s BioCells Inc Expands Presence
    • 112th Congress Introduces Family Cord Blood Banking Act
    • Nanshan Memorial Medical Institute Utilizes Cord Blood Stem Cell Processing and Storage Technologies from Thermogenesis
    • BoyaLife Adopts ThermoGenesis' Cord Blood Products
    • Cryo-Save India to Enhance Cord Blood Banking Operations
    • PerkinElmer' s ViaCordR Family Cord Blood Banking Division Offers New Service
    • Fortis Collaborates with TotipotentRX Cell Therapy Pvt Ltd
    • ThermoGenesis in Partnership with Chinese Stem Cell Company
    • Cord Blood America Acquires Minority Stake in Stem Cells VIDAPLUS
    • Progenitor Cell Therapy Acquired by NeoStem
    • ViaCord' s 200th Umbilical Cord Blood Unit for Stem Cell Treatment
    • Cord Blood America Commences Storage of Stem Cells from Dental Pulp BioCells, Inc
    • Cord Blood America to Take Over Cryo-Cell Mexico
    • Cord Blood America Endorses US Government Recognition for Umbilical Cord Blood Stem Cell Storage
    • New Services for Stem Cell Banking Launched by CordLife
    • StemCyte Collaborates with Sharp HealthCare
    • Cord Blood America Acquires stellacure GmbH
    • Cord Life India to Launch Services in Mumbai
    • Riverside Co Acquires Celvitae Biomedica S.A.
    • Cord Blood America on an Expansion Spree
    • CordLife' s Advanced Human Stem Cell Debuts in Hong Kong
    • StemCyte' s First Stem Cell Bank Opened in India
    • First Cord Blood Processing and Cryopreservation Facility Opens in the Philippines
    • PathCare Labs Launches Cord Care
    • Cord Blood America Enters into a Contract with BioE
  • 1.8 GLOBAL MARKET OVERVIEW
    • 1.8.1 Market Overview by Stem Cell Technology
    • 1.8.2 Market Overview by Stem Cell Stem Cell Therapeutic Area
    • 1.8.3 Stem Cell Technology Market Overview by Global Region
      • 1.8.3.1 Stem Cell Transplant
      • 1.8.3.2 Cord Blood Banking
      • 1.8.3.3 Blood Transfusion
      • 1.8.3.4 Cell Based Genetics
      • 1.8.3.5 Xenotransplant
    • 1.8.4 Stem Cell Therapeutic Market Overview by Global Region
      • 1.8.4.1 Neurology
      • 1.8.4.2 Oncology
      • 1.8.4.3 Cardiology
      • 1.8.4.4 Cartilage
      • 1.8.4.5 Blood Disorders
      • 1.8.4.6 Diabetes
      • 1.8.4.7 Dermatology
      • 1.8.4.8 Other Disease Areas

2. REGIONAL MARKET PERSPECTIVE REGIONAL MARKET OVERVIEW

  • 2.1 NORTH AMERICA
    • 2.1.1 Market Overview by North American Region
    • 2.1.2 Market Overview by Stem Cell Technology
    • 2.1.3 Market Overview by Stem Cell Stem Cell Therapeutic Area
    • 2.1.4 Stem Cell Technology Market Overview by North American Region
      • 2.1.4.1 Stem Cell Transplant
      • 2.1.4.2 Cord Blood Banking
      • 2.1.4.3 Blood Transfusion
      • 2.1.4.4 Cell Based Genetics
      • 2.1.4.5 Xenotransplant
    • 2.1.5 Major Market Players
      • Advanced Cell Technology, Inc. (USA)
      • Aldagen, Inc. (USA)
      • AlphaCord (USA)
      • Americord Registry LLC (USA)
      • Becton, Dickinson And Company (USA)
      • BioE (USA)
      • Carolinas CBB (USA)
      • Cells for Life (Canada)
      • CorCell (USA)
      • Cord Blood America Inc. (USA)
      • Cord Blood Solutions, LLC (USA)
      • CordBancUSA (USA)
      • Cordon Vital (Mexico)
      • Coriell (USA)
      • CryoBanks International (USA)
      • Cryo-Cell International (USA)
      • DomaniCell, LLC (USA)
      • Family CB Services (USA)
      • Genecell International LLC (GCI) (USA)
      • Geron Corporation (USA)
      • HemaStem Therapeutics (Canada)
      • ITxM (USA)
      • J.P. McCarthy Cord Stem Cell Bank (USA)
      • Life Source (USA)
      • LifeBankUSA (USA)
      • Lifeforce Cryobank Sciences Inc (USA)
      • LifeCell Corporation (USA)
      • LifeLine Cryogenics (USA)
      • Lifesource Cryobank LLC (USA)
      • MAZE Labs (USA)
      • New England Cord Blood Bank (USA)
      • NeoCells (USA)
      • Neostem Inc (USA)
      • NYBC National Cord Blood Program (USA)
      • Osiris Therapeutics, Inc. (USA)
      • Perkinelmer Inc (USA)
      • Rhode Island Blood Center (USA)
      • StemCell Technologies Inc. (USA)
      • Stemcyte (USA)
      • Umbilical Cord Blood Bank (Canada)
      • ViaCell, Inc. (USA)
      • ViaCord, Inc (USA)
    • 2.1.6 North American Market Overview by Country
      • 2.1.6.1 The United States
      • 2.1.6.2 Canada
      • 2.1.6.3 Mexico
  • 2.2 EUROPE
    • 2.2.1 Market Overview by European Region
    • 2.2.2 Market Overview by Stem Cell Technology
    • 2.2.3 Market Overview by Stem Cell Stem Cell Therapeutic Area
    • 2.2.4 Stem Cell Technology Market Overview by European Region
      • 2.2.4.1 Stem Cell Transplant
      • 2.2.4.2 Cord Blood Banking
      • 2.2.4.3 Blood Transfusion
      • 2.2.4.4 Cell Based Genetics
      • 2.2.4.5 Xenotransplant
    • 2.2.5 Major Market Players
      • Activision Life SA (Denmark)
      • Angel Biotechnology (UK)
      • Banco De Celulas Madre (Spain)
      • Crio-Cord (Spain)
      • Cryo-Save Group Nv (The Netherlands)
      • Cytolon AG (Germany)
      • Eticur (Germany)
      • Future Health Technologies (UK)
      • Life Cells (UK)
      • Procrea Stem Cells (Switzerland)
      • Progenis (Poland)
      • Swiss Blood Stem Cells (Switzerland)
      • Vita Cord (Austria)
    • 2.2.6 European Market Overview by Country
      • 2.2.6.1 The United Kingdom
      • 2.2.6.2 Germany
      • 2.2.6.3 France
      • 2.2.6.4 Spain
      • 2.2.6.5 Russia
      • 2.2.6.6 Sweden
      • 2.2.6.7 Switzerland
      • 2.2.6.8 Rest of Europe
  • 2.3 ASIA-PACIFIC
    • 2.3.1 Market Overview by Asia-Pacific Region
    • 2.3.2 Market Overview by Stem Cell Technology
    • 2.3.3 Market Overview by Stem Cell Stem Cell Therapeutic Area
    • 2.3.4 Stem Cell Technology Market Overview by Asia-Pacific Region
      • 2.3.4.1 Stem Cell Transplant
      • 2.3.4.2 Cord Blood Banking
      • 2.3.4.3 Blood Transfusion
      • 2.3.4.4 Cell Based Genetics
      • 2.3.4.5 Xenotransplant
    • 2.3.5 Major Market Players
      • BioCell (Australia)
      • Cellsafe International Group (Malaysia)
      • Cell Care Pty Ltd (Australia)
      • China Cord Blood Corporation (China)
      • Cord Bank (New Zealand)
      • Cord Life Ltd (Singapore)
      • Cordlife Group (Australia)
      • Cordlife (Hong Kong) Limited
      • CryoCord (Malaysia)
      • Cryosite Ltd (Australia)
      • Cryo Stemcell (Kar) Pvt. Ltd (India)
      • CyGenics Ltd (Australia)
      • Golden MediTech Company (China)
      • Histostem Co Ltd (South Korea)
      • Jeevan Stem Cell Bank (India)
      • Kaneka Corporation (Japan)
      • Life Cord (South Korea)
      • Reliance Life Sciences (India)
      • Shandong Umbilical Cord Blood Center (China)
      • Singapore Cord Blood Bank, Ltd. (Singapore)
      • Stem Cell Institute (Japan)
      • Stemone Biologicals Pvt. Ltd. (India)
      • Stem Life (Malaysia)
      • Sydney Cord Blood Bank (Australia)
    • 2.3.6 Asia-Pacific Market Overview by Country
      • 2.3.6.1 India
      • 2.3.6.2 China
      • 2.3.6.3 Japan
      • 2.3.6.4 Australia
      • 2.3.6.5 South Korea
      • 2.3.6.6 Hong Kong
      • 2.3.6.7 Singapore
      • 2.3.6.8 Rest of Asia-Pacific
  • 2.4 REST OF WORLD
    • 2.4.1 Market Overview by Rest of World Region
    • 2.4.2 Market Overview by Stem Cell Technology
    • 2.4.3 Market Overview by Stem Cell Stem Cell Therapeutic Area
    • 2.4.4 Major Market Players
      • Babycord Jordan (Jordan)
      • Banco De Cordon Umbilical (Peru)
      • BioCord (Israel)
      • Cryo-Save (South Africa)
      • Gamida Cell Limited (Israel)
      • Hemocord (Brazil)
      • Med Cells International FZ LLC (United Arab Emirates)

3. GUIDE TO THE INDUSTRY

  • 3.1 PUBLIC CORD BLOOD BANKS
    • 3.1.1 North America
    • 3.1.2 Europe
    • 3.1.3 Asia-Pacific
    • 3.1.4 Rest of World
  • 3.2 PRIVATE CORD BLOOD BANKS
    • 3.2.1 North America
    • 3.2.2 Europe
    • 3.2.3 Asia-Pacific
    • 3.2.4 Rest of World

4. ANNEXURE

  • 4.1 RESEARCH METHODOLOGY
  • 4.2 THE QUESTIONNAIRE
  • 4.3 FEEDBACK

Charts & Graphs

1. GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Cord Blood Units Collected (2000-2008) by Public Cord Blood Banks in Thousands
  • Chart 2: Cord Blood Stem Cell Units Collected by Public Cord Blood Banks in Select Countries (2000-2010) - Australia, Brazil, Canada, France, Japan, Spain, United Kingdom and United States
  • Chart 3: Cord Blood Stem Cell Units Collected by Private Cord Blood Banks in Select Countries (2010) - Australia, Brazil, Canada, France, Japan, Spain, United Kingdom and United States
  • Chart 4: Global Cord Blood Stem Cells Market Analysis (2006-2015) in USD Million
  • Chart 5: Global Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 6: Glance at 2006, 2012 and 2015 Global Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant
  • Chart 7: Global Cord Blood Stem Cells Market Analysis (2006-2015) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other in USD Million
  • Chart 8: Glance at 2006, 2012 and 2015 Global Cord Blood Stem Cells Market Share (%)by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other
  • Chart 9: Global Stem Cell Transplant Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 10: Glance at 2006, 2012 and 2015 Global Stem Cell Transplant Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 11: Global Cord Blood Banking Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 12: Glance at 2006, 2012 and 2015 Global Cord Blood Banking Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 13: Global Blood Transfusion Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 14: Glance at 2006, 2012 and 2015 Global Blood Transfusion Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 15: Global Cell Based Genetics Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 16: Glance at 2006, 2012 and 2015 Global Cell Based Genetics Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 17: Global Xenotransplant Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 18: Glance at 2006, 2012 and 2015 Global Xenotransplant Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 19: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Neurology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 20: Glance at 2006, 2012 and 2015 Global Neurology Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 21: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Oncology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 22: Glance at 2006, 2012 and 2015 Global Oncology Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 23: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Cardiology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 24: Glance at 2006, 2012 and 2015 Global Cardiology Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 25: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Cartilage by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 26: Glance at 2006, 2012 and 2015 Global Cartilage Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 27: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Blood Disorders by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 28: Glance at 2006, 2012 and 2015 Global Blood Disorders Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 29: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Diabetes by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 30: Glance at 2006, 2012 and 2015 Global Diabetes Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 31: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Dermatology by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 32: Glance at 2006, 2012 and 2015 Global Dermatology Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World
  • Chart 33: Global Cord Blood Stem Cells Market Analysis (2006-2015) in Other Disease Areas by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 34: Glance at 2006, 2012 and 2015 Global Other Disease Areas Market Share (%) of Cord Blood Stem Cells by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

2. REGIONAL MARKET PERSPECTIVE

  • Chart 35: The Projection of Largest Regions in terms of Market Growth for Cord Blood Stem Cells by Geography - Asia-Pacific, Europe, North America and Rest of World (South America, Middle East and Africa)
  • Chart 36: Global Cord Blood Stem Cells Market Analysis (2006-2015) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World in USD Million
  • Chart 37: Glance at 2006, 2012 and 2015 Global Cord Blood Stem Cells Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 38: North American Cord Blood Stem Cells Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 39: Glance at 2006, 2012 and 2015 North American Cord Blood Stem Cells Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 40: North American Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 41: Glance at 2006, 2012 and 2015 North American Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant
  • Chart 42: North American Cord Blood Stem Cells Market Analysis (2006-2015) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other in USD Million
  • Chart 43: Glance at 2006, 2012 and 2015 North American Cord Blood Stem Cells Market Share (%)by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other
  • Chart 44: North American Stem Cell Transplant Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 45: Glance at 2006, 2012 and 2015 North American Stem Cell Transplant Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 46: North American Cord Blood Banking Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 47: Glance at 2006, 2012 and 2015 North American Cord Blood Banking Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 48: North American Blood Transfusion Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 49: Glance at 2006, 2012 and 2015 North American Blood Transfusion Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 50: North American Cell Based Genetics Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 51: Glance at 2006, 2012 and 2015 North American Cell Based Genetics Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 52: North American Xenotransplant Market Analysis (2006-2015) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 53: Glance at 2006, 2012 and 2015 North American Xenotransplant Market Share (%) by Geographic Region - United States, Canada and Mexico

The United States

  • Chart 54: United States Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 55: Glance at 2006, 2012 and 2015 United States Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Canada

  • Chart 56: Canadian Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 57: Glance at 2006, 2012 and 2015 Canadian Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Mexico

  • Chart 58: Mexican Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 59: Glance at 2006, 2012 and 2015 Mexican Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

EUROPE

  • Chart 60: European Cord Blood Stem Cells Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 61: Glance at 2006, 2012 and 2015 European Cord Blood Stem Cells Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe
  • Chart 62: European Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 63: Glance at 2006, 2012 and 2015 European Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant
  • Chart 64: European Cord Blood Stem Cells Market Analysis (2006-2015) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other in USD Million
  • Chart 65: Glance at 2006, 2012 and 2015 European Cord Blood Stem Cells Market Share (%)by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other
  • Chart 66: European Stem Cell Transplant Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 67: Glance at 2006, 2012 and 2015 European Stem Cell Transplant Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe
  • Chart 68: European Cord Blood Banking Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 69: Glance at 2006, 2012 and 2015 European Cord Blood Banking Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe
  • Chart 70: European Blood Transfusion Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 71: Glance at 2006, 2012 and 2015 European Blood Transfusion Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe
  • Chart 72: European Cell Based Genetics Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 73: Glance at 2006, 2012 and 2015 European Cell Based Genetics Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe
  • Chart 74: European Xenotransplant Market Analysis (2006-2015) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe in USD Million
  • Chart 75: Glance at 2006, 2012 and 2015 European Xenotransplant Market Share (%) by Geographic Region - United Kingdom, Germany, France, Spain, Russia, Sweden, Switzerland and Rest of Europe

The United Kingdom

  • Chart 76: United Kingdom Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 77: Glance at 2006, 2012 and 2015 United Kingdom Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Germany

  • Chart 78: German Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 79: Glance at 2006, 2012 and 2015 German Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

France

  • Chart 80: French Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 81: Glance at 2006, 2012 and 2015 French Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Spain

  • Chart 82: Spanish Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 83: Glance at 2006, 2012 and 2015 Spanish Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Russia

  • Chart 84: Russian Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 85: Glance at 2006, 2012 and 2015 Russian Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Sweden

  • Chart 86: Swedish Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 87: Glance at 2006, 2012 and 2015 Swedish Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Switzerland

  • Chart 88: Swiss Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 89: Glance at 2006, 2012 and 2015 Swiss Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Rest of Europe

  • Chart 90: Rest of Europe Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 91: Glance at 2006, 2012 and 2015 Rest of Europe Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

ASIA-PACIFIC

  • Chart 92: Asia-Pacific Cord Blood Stem Cells Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 93: Glance at 2006, 2012 and 2015 Asia-Pacific Cord Blood Stem Cells Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific
  • Chart 94: Asia-Pacific Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 95: Glance at 2006, 2012 and 2015 Asia-Pacific Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant
  • Chart 96: Asia-Pacific Cord Blood Stem Cells Market Analysis (2006-2015) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other in USD Million
  • Chart 97: Glance at 2006, 2012 and 2015 Asia-Pacific Cord Blood Stem Cells Market Share (%) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other
  • Chart 98: Asia-Pacific Stem Cell Transplant Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 99: Glance at 2006, 2012 and 2015 Asia-Pacific Stem Cell Transplant Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific
  • Chart 100: Asia-Pacific Cord Blood Banking Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 101: Glance at 2006, 2012 and 2015 Asia-Pacific Cord Blood Banking Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific
  • Chart 102: Asia-Pacific Blood Transfusion Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 103: Glance at 2006, 2012 and 2015 Asia-Pacific Blood Transfusion Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific
  • Chart 104: Asia-Pacific Cell Based Genetics Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 105: Glance at 2006, 2012 and 2015 Asia-Pacific Cell Based Genetics Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific
  • Chart 106: Asia-Pacific Xenotransplant Market Analysis (2006-2015) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific in USD Million
  • Chart 107: Glance at 2006, 2012 and 2015 Asia-Pacific Xenotransplant Market Share (%) by Geographic Region - India, China, Japan, Australia, South Korea, Hong Kong, Singapore and Rest of Asia-Pacific

India

  • Chart 108: Indian Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 109: Glance at 2006, 2012 and 2015 Indian Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

China

  • Chart 110: Chinese Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 111: Glance at 2006, 2012 and 2015 Chinese Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Japan

  • Chart 112: Japanese Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 113: Glance at 2006, 2012 and 2015 Japanese Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Australia

  • Chart 114: Australian Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 115: Glance at 2006, 2012 and 2015 Australian Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

South Korea

  • Chart 116: South Korean Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 117: Glance at 2006, 2012 and 2015 South Korean Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Hong Kong

  • Chart 118: Hong Kong Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 119: Glance at 2006, 2012 and 2015 Hong Kong Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Singapore

  • Chart 120: Singaporean Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 121: Glance at 2006, 2012 and 2015 Singaporean Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

Rest of Asia-Pacific

  • Chart 122: Rest of Asia-Pacific Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 123: Glance at 2006, 2012 and 2015 Rest of Asia-Pacific Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant

REST OF WORLD

  • Chart 124: Rest of World Cord Blood Stem Cells Market Analysis (2006-2015) by Geographic Region - Brazil, Columbia, Argentina, Israel, Africa and Other in USD Million
  • Chart 125: Glance at 2006, 2012 and 2015 Rest of World Cord Blood Stem Cells Market Share (%) by Geographic Region - Brazil, Columbia, Argentina, Israel, Africa and Other
  • Chart 126: Rest of World Cord Blood Stem Cells Market Analysis (2006-2015) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant in USD Million
  • Chart 127: Glance at 2006, 2012 and 2015 Rest of World Cord Blood Stem Cells Market Share (%) by Stem Cell Technology - Stem Cell Transplant, Cord Blood Banking, Blood Transfusion, Cell Based Genetics and Xenotransplant
  • Chart 128: Rest of World Cord Blood Stem Cells Market Analysis (2006-2015) by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other in USD Million
  • Chart 129: Glance at 2006, 2012 and 2015 Rest of World Cord Blood Stem Cells Market Share (%)by Therapeutic Area - Neurology, Oncology, Cardiology, Cartilage, Blood Disorders, Diabetes, Dermatology and Other

MAJOR GLOBAL MARKET PLAYERS:

  • Activision Life SA
  • Advanced Cell Technology, Inc.
  • AlphaCord
  • Angel Biotechnology
  • Babycord Jordan
  • Banco De Celulas Madre
  • Banco De Cordon Umbilical
  • Becton, Dickinson and Company
  • BioCell Pty. Ltd.
  • BioCord
  • Carolinas CBB
  • Cells for Life
  • CorCell
  • Cord Bank
  • Cord Blood America Inc.
  • Cord Blood Registry
  • Cord Life Ltd
  • Cordlife Group
  • Cordon Vital
  • Coriell
  • Crio-Cord
  • Cryo Stemcell (Kar) Pvt. Ltd
  • CryoBanks International
  • Cryo-Cell International
  • CryoCord
  • Cryo-Save
  • Cryo-Save Group NV
  • CyGenics Ltd
  • Cytolon AG
  • DomaniCell, LLC
  • Eticur
  • Family CB Services
  • Future Health Technologies
  • Genecell International LLC (GCI)
  • Geron Corporation
  • Golden MediTech Company
  • HemaStem Therapeutics
  • J.P. McCarthy Cord Stem Cell Bank
  • Kaneka Corporation
  • Life Cells
  • Life Cord
  • Life Source
  • LifeBankUSA
  • Med Cells International FZ LLC
  • New England Cord Blood Bank
  • NYBC National Cord Blood Program
  • Osiris Therapeutics, Inc.
  • Perkinelmer Inc
  • Reliance Life Sciences
  • Shandong Umbilical Cord Blood Center
  • Singapore Cord Blood Bank, Ltd.
  • Stem Cell Institute
  • Stem Life
  • StemCell Technologies Inc.
  • Swiss Blood Stem Cells
  • Sydney Cord Blood Bank
  • ViaCord, Inc
  • Vita Cord

Press Release

2012年之前臍帶血幹細胞的全球市場將達到72億美元規模

2011年11月07日

Global Information, Inc.已開始銷售Industry Experts所發行的報告書「Cord Blood Stem Cells - A Global Market Overview (臍帶血幹細胞：全球市場概要)」

2011年全球臍帶血幹細胞市場是56億美元規模，本報告書預測2012年之前將達到72億美元。

由於科學技術的進步，再生醫療可利用的臍帶血保存數增加。

妊娠中父母能決定要保存孩子的臍帶血。將來可能會採用該幹細胞用來進行損壞的心臟組織之修復和置換等治療。

幼兒的臍帶血提供對心力衰竭等未來不能預見的突發性疾病最理想的治療法。

最新再生醫療的事例已確實證明使用自己幹細胞的治療帶來最佳結果的可能性很高。

本報告書分析的臍帶血幹細胞技術是幹細胞移植、臍帶銀行、輸血、細胞基因治療與異種移植。此外，亦分析由神經學、腫瘤學、心臟病學、軟骨疾病、血液疾病、糖尿病及皮膚科學等構成幹細胞治療領域的全球市場。

推定2010年年底，全世界的公共臍帶血銀行所保存的臍帶血數將超過45萬袋以上，而民間的臍帶血銀行則超過100萬袋。
Back to Top